Evidence map›Paper›PMID 35395329›Full record

ArticleNeurotoxicology2022

Shedding light on the toxicity of SARS-CoV-2-derived peptide in non-target COVID-19 organisms: A study involving inbred and outbred mice.

Thiarlen Marinho da Luz, Amanda Pereira da Costa Araújo, Fernanda Neves Estrêla Rezende, Abner Marcelino Silva, Ives Charlie-Silva, Helyson Lucas Bezerra Braz, Paulo R S Sanches, Md Mostafizur Rahman, Damià Barceló, Guilherme Malafaia

Open access · bronzeAbstract read
In one paragraph

Article in Neurotoxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Thiarlen Marinho da LuzBiological Research Laboratory, Goiano Federal Institute, Urutaí, GO, Brazil.
Amanda Pereira da Costa AraújoBiological Research Laboratory, Goiano Federal Institute, Urutaí, GO, Brazil; Post-Graduation Program in Environmental Sciences, Federal University of Goiás, Goiânia, GO, Brazil.
Fernanda Neves Estrêla RezendeBiological Research Laboratory, Goiano Federal Institute, Urutaí, GO, Brazil.
Abner Marcelino SilvaBiological Research Laboratory, Goiano Federal Institute, Urutaí, GO, Brazil.
Ives Charlie-SilvaDepartment of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Sao Paulo, SP, Brazil.
Helyson Lucas Bezerra BrazDrug Research and Development Center, Federal University of Ceará, Fortaleza, CE, Brazil.
Paulo R S SanchesInstitute of Chemistry, São Paulo State University, Araraquara, SP, Brazil.
Md Mostafizur RahmanLaboratory of Environmental Health and Ecotoxicology, Department of Environmental Sciences, Jahangirnagar University, Dhaka 1342, Bangladesh.
Damià BarcelóCatalan Institute for Water Research (ICRA-CERCA), H2O Building, Scientific and Technological Park of the University of Girona, Emili Grahit 101, 17003 Girona, Spain; Water and Soil Quality Research Group, Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA-CSIC), JordiGirona 1826, 08034 Barcelona, Spain.
Guilherme MalafaiaBiological Research Laboratory, Goiano Federal Institute, Urutaí, GO, Brazil; Post-Graduation Program in Conservation of Cerrado Natural Resources, Goiano Federal Institute, Urutaí, GO, Brazil; Post-Graduation Program in Ecology, Conservation, and Biodiversity, Federal University of Uberlândia, Uberlândia, MG, Brazil; Post-Graduation Programa in Biotechnology and Biodiversity, Federal University of Goiás, Goiânia, GO, Brazil. Electronic address: guilherme.malafaia@ifgoiano.edu.br.
Instituto Federal Goiano · BRUniversidade Federal de Goiás · BRInstitute of Environmental Assessment and Water Research · ESJahangirnagar University · BDUniversidade de São Paulo · BRUniversidade Estadual Paulista (Unesp) · BRUniversidade Federal do Ceará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite advances in research on the vaccine and therapeutic strategies of COVID-19, little attention has been paid to the possible (eco)toxicological impacts of the dispersion of SARS-CoV-2 particles in natural environments. Thus, in this study, we aimed to evaluate the behavioral and biochemical consequences of the short exposure of outbred and inbred mice (male Swiss and C57Bl/6 J mice, respectively) to PSPD-2002 (peptide fragments of the Spike protein of SARS-CoV-2) synthesized in the laboratory. Our data demonstrated that after 24 h of intraperitoneal administration of PSPD-2002 (at 580 μg/kg) the animals did not present alterations in their locomotor, anxiolytic-like, or anxiety-like behavior (in the open field test), nor antidepressant-like or depressive behavior in the forced swimming test. However, the C57Bl/6 J mice exposed to PSPD-2002 showed memory deficit in the novel object recognition task, which was associated with higher production of thiobarbituric acid reactive substances, as well as the increased suppression of acetylcholinesterase brain activity, compared to Swiss mice also exposed to peptide fragments. In Swiss mice the reduction in the activity of superoxide dismutase and catalase in the brain was not associated with increased oxidative stress biomarkers (hydrogen peroxide), suggesting that other antioxidant mechanisms may have been activated by exposure to PSPD-2002 to maintain the animals' brain redox homeostasis. Finally, the results of all biomarkers evaluated were applied into the "Integrated Biomarker Response Index" (IBRv2) and the principal component analysis (PCA), and greater sensitivity of C57Bl/6 J mice to PSPD-2002 was revealed. Therefore, our study provides pioneering evidence of mammalian exposure-induced toxicity (non-target SARS-CoV-2 infection) to PSPD-2002, as well as "sheds light" on the influence of genetic profile on susceptibility/resistance to the effects of viral peptide fragments.

Indexed as

COVID-19SARS-CoV-2AcetylcholinesteraseAnimalsBiomarkersMaleMammalsMiceMice, Inbred C57BLPeptide FragmentsPeptidesAcetylcholinesteraseBiomarkersPeptide FragmentsPeptidesC57Bl/6 J miceEnvironmental ToxicologyPandemic COVID-19ProteinsSwiss mice

Identifiers

PMID35395329
PMCPMC8982478
OpenAlexW4223624008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.